指南与共识胸部技术与安全CT

在超重和肥胖人群中满足ACR肺癌筛查CT剂量指南

Meeting ACR Dose Guidelines for CT Lung Cancer Screening in an Overweight and Obese Population.
指南 / 共识 · Acad Radiol · 2020-04-10

研究纳入2012年12月至2017年12月共1478例基线肺癌筛查CT患者,按BMI分类分析辐射剂量指标。结果显示所有BMI分类和性别均满足ACR剂量要求,本 program 平均CTDIvol和有效剂量低于2017年全国平均水平,肥胖患者剂量也低于全国肥胖患者。

要点

  • 在超重和肥胖为主的筛查人群中,CT剂量可满足ACR肺癌筛查剂量指南。
  • 男性剂量指标高于女性,相同BMI分类内男女剂量差异有统计学意义(p < 0.001)。
  • 本 program 平均CTDIvol 2.45 ± 1.14 mGy、有效剂量1.26 ± 0.59 mSv,低于2017年全国平均3.24 mGy和1.35 mSv。

临床应用与阅片要点

  • 可按BMI分类对肺癌筛查CT的辐射剂量进行适当调整。
  • 肥胖患者中本 program 平均剂量指标低于全国肥胖患者平均水平。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Lung cancer screening adoption coincides with a growing obesity epidemic. Maintaining high-quality imaging at low radiation dose is challenging in obesity. We investigate the feasibility of meeting American College of Radiology (ACR) dose guidelines for lung cancer screening in a predominantly overweight and obese population.

MATERIALS AND METHODS: Radiation dose (Volumetric CT dose index [CTDIvol], dose-length product), and body mass index (BMI) were collected for baseline screening CTs December, 2012-December, 2017. Dose metrics were analyzed according to BMI classification (normal <25, overweight 25-29, obese ≥30 kg/m2), using k = 0.014 mSv/mGy*cm. Results were compared to ACR dose guidelines and mean national 2017 Lung Cancer Screening Registry dose metrics. Analysis used Kruskal-Wallis (SPSS, version 24.0.0, IBM corp, Armonk, NY).

RESULTS: Study population comprised 1478 patients (49.2% [727] women: mean BMI 28.1 ± 6.5 kg/m2, 26.9% [397] normal weight, 35.9% [530] overweight, 37.2% [551] obese). ACR dose requirements were met for both genders in all BMI classifications. Dose metrics were higher in men than in women; median effective dose and CTDIvol were 1.39 (0.8-1.58) mSv and 2.78 (1.41-2.80) mGy in men versus 1.16 (0.71-1.43) mSv and 2.70 (1.4-2.78) mGy in women. There were significant differences in dose metrics between men and women in the same BMI classification and between BMI classifications (p < 0.001). Mean dose metrics in our program were considerably lower than 2017 national average- mean CTDIvol and effective dose 2.45 ± 1.14 mGy and 1.26 ± 0.59 mSv versus 3.24 mGy and 1.35 mSv, respectively for our program and nationally. Mean dose metrics were also lower in our obese patients versus obese patients nationally.

CONCLUSION: ACR dose metrics for lung cancer screening were met and can be appropriately tailored in a predominantly overweight and obese population clinical program.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Peng R, Mardakhaev E, Shmukler A, et al. Meeting ACR Dose Guidelines for CT Lung Cancer Screening in an Overweight and Obese Population. Acad Radiol. 2020. PMID: 32284173. doi:10.1016/j.acra.2020.02.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。